MedTrace Logo

Zilver PTX Post-Market Study in Japan

NCT02254837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 909

Last updated 2019-07-12

No results posted yet for this study

Summary

Japanese post market clinical study of the Zilver PTX device.

Conditions

  • Peripheral Arterial Disease (PAD)

Interventions

DEVICE

Zilver PTX Drug-Eluting Stent

Sponsors & Collaborators

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Michael D Dake, MD · Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2018-06-30
Completion
2018-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02254837 on ClinicalTrials.gov